neutral
8h agoMedline IPO Soars 41% After $6.3 Billion Offering, a Major Win for Private Equity
Medline Industries, a private equity-backed medical supply company, saw its stock surge by 41% in its Wall Street debut on Wednesday, following the completion of a $6.3 billion initial public offering (IPO). The offering was the largest of 2025, eclipsing the $5.4 billion Medline had originally anticipated and surpassing the $5.3 billion raised by CATL earlier in the year. Medline’s shares closed at $41, significantly above the initial price of $29 per share.
neutral
8h agoMedline IPO Soars 41% After $6.3 Billion Offering, a Major Win for Private Equity
Medline Industries, a private equity-backed medical supply company, saw its stock surge by 41% in its Wall Street debut on Wednesday, following the completion of a $6.3 billion initial public offering (IPO). The offering was the largest of 2025, eclipsing the $5.4 billion Medline had originally anticipated and surpassing the $5.3 billion raised by CATL earlier in the year. Medline’s shares closed at $41, significantly above the initial price of $29 per share.
1 min read
73 words
Medline’s IPO raises $6.3 billion, with shares soaring 41% in its debut. This marks the biggest private equity-backed IPO of 2025, signaling strong investor confidence.
Medline Industries, a private equity-backed medical supply company, saw its stock surge by 41% in its Wall Street debut on Wednesday, following the completion of a $6.3 billion initial public offering (IPO). The offering was the largest of 2025, eclipsing the $5.4 billion Medline had originally anticipated and surpassing the $5.3 billion raised by CATL earlier in the year. Medline’s shares closed at $41, significantly above the initial price of $29 per share.
Medline Industries, a private equity-backed medical supply company, saw its stock surge by 41% in its Wall Street debut on Wednesday, following the completion of a $6.3 billion initial public offering (IPO). The offering was the largest of 2025, eclipsing the $5.4 billion Medline had originally anticipated and surpassing the $5.3 billion raised by CATL earlier in the year. Medline’s shares closed at $41, significantly above the initial price of $29 per share.
Dec 18, 2025 • 07:50